Literature DB >> 22923189

Schizophrenia: from risk genes to outcome and comorbidity.

Andrea Schmitt, Peter Falkai.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22923189     DOI： 10.1007/s00406-012-0358-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  8 in total

1.  A comparison of adolescent- and adult-onset first-episode, non-affective psychosis: 2-year follow-up.

Authors:  Johannes Langeveld; Inge Joa; Svein Friis; Wenche ten Velden Hegelstad; Ingrid Melle; Jan O Johannessen; Stein Opjordsmoen; Erik Simonsen; Per Vaglum; Bjørn Auestad; Thomas McGlashan; Tor K Larsen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

2.  Dissociable morphometric differences of the inferior parietal lobule in schizophrenia.

Authors:  Lena Palaniyappan; Peter F Liddle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-28       Impact factor: 5.270

3.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

4.  Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder.

Authors:  Bartosz Zurowski; Andreas Kordon; Wolfgang Weber-Fahr; Ulrich Voderholzer; Anne Katrin Kuelz; Tobias Freyer; Karina Wahl; Christian Büchel; Fritz Hohagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

5.  Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.

Authors:  Leonhard Lennertz; Friederike Rampacher; Andrea Vogeley; Svenja Schulze-Rauschenbach; Ralf Pukrop; Stephan Ruhrmann; Joachim Klosterkötter; Wolfgang Maier; Peter Falkai; Michael Wagner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

6.  Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.

Authors:  Reinhold Kilian; Tilman Steinert; Wiltrud Schepp; Prisca Weiser; Susanne Jaeger; Carmen Pfiffner; Karel Frasch; Gerhard W Eschweiler; Thomas Messer; Daniela Croissant; Thomas Becker; Gerhard Längle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-04-22       Impact factor: 5.270

7.  D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians.

Authors:  Dimitrios Andreou; Peter Saetre; Thomas Werge; Ole A Andreassen; Ingrid Agartz; Göran C Sedvall; Håkan Hall; Lars Terenius; Erik G Jönsson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-28       Impact factor: 5.270

8.  Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.

Authors:  Andrea Schmitt; Fernando Leonardi-Essmann; Pascal F Durrenberger; Sven P Wichert; Rainer Spanagel; Thomas Arzberger; Hans Kretzschmar; Mathias Zink; Mario Herrera-Marschitz; Richard Reynolds; Moritz J Rossner; Peter Falkai; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.